Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2'-((5-(4-methyl-1-piperazinyl)-2-pyridinyl)amino)-7',8'-dihydro-6'h-spiro(cyclohexane-1,9'-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one
2. Cosela
3. Spiro(cyclohexane-1,9'(6'h)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one, 7',8'-dihydro-2'-((5-(4-methyl-1-piperazinyl)-2-pyridinyl)amino)-
4. Trilaciclib
1. 1977495-97-8
2. Trilaciclib Dihydrochloride
3. Trilaciclib 2hcl
4. G1t28 Hydrochloride
5. G1t28 Dihydrochloride
6. Trilaciclib (hydrochloride)
7. 4bx07w725t
8. Cosela
9. 2'-((5-(4-methylpiperazin-1-yl)pyridin-2-yl)amino)-7',8'-dihydro-6'hspiro(cyclohexane-1,9'-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one Dihydrochloride
10. 4-[[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino]spiro[1,3,5,11-tetrazatricyclo[7.4.0.02,7]trideca-2,4,6,8-tetraene-13,1'-cyclohexane]-10-one;dihydrochloride
11. Spiro(cyclohexane-1,9'(6'h)-pyrazino(1',2':1,5)pyrrolo(2,3-d)pyrimidin)-6'-one, 7',8'-dihydro-2'-((5-(4-methyl-1-piperazinyl)-2-pyridinyl)amino)-, Hydrochloride (1:2)
12. Unii-4bx07w725t
13. Chembl4650272
14. Trilaciclib Hydrochloride(g1t28)
15. Bcp25727
16. Ced49597
17. Ex-a4296
18. At27978
19. Cs-7942
20. Hy-101467a
21. Sb19784
22. G1t28 Dihydrochloride;trilaciclib 2hcl
23. G1t28 Hydrochlorideg1t28 Hydrochloride
24. Ac-36548
25. Trilaciclib Dihydrochloride [who-dd]
26. Trilaciclib Dihydrochloride [orange Book]
27. A901868
28. 12'-{[5-(4-methylpiperazin-1-yl)pyridin-2-yl]amino}-2',5',11',13'-tetraazaspiro[cyclohexane-1,3'-tricyclo[7.4.0.0(2),]tridecane]-1'(9'),7',10',12'-tetraen-6'-one Dihydrochloride
29. 1374635-07-0
Molecular Weight | 519.5 g/mol |
---|---|
Molecular Formula | C24H32Cl2N8O |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 3 |
Exact Mass | g/mol |
Monoisotopic Mass | g/mol |
Topological Polar Surface Area | 91.2 |
Heavy Atom Count | 35 |
Formal Charge | 0 |
Complexity | 707 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Chunghwa provides cost-effective APIs & advanced intermediates with complete DMF or COS, ensuring quality & reliable production.
NDC Package Code : 52076-6275
Start Marketing Date : 2022-10-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2024-07-09
Pay. Date : 2024-06-13
DMF Number : 40022
Submission : 2024-06-20
Status : Active
Type : II
NDC Package Code : 17337-0438
Start Marketing Date : 2024-05-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Complete
Rev. Date : 2024-07-09
Pay. Date : 2024-06-13
DMF Number : 40022
Submission : 2024-06-20
Status : Active
Type : II
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Trilaciclib Dihydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trilaciclib Dihydrochloride, including repackagers and relabelers. The FDA regulates Trilaciclib Dihydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trilaciclib Dihydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trilaciclib Dihydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trilaciclib Dihydrochloride supplier is an individual or a company that provides Trilaciclib Dihydrochloride active pharmaceutical ingredient (API) or Trilaciclib Dihydrochloride finished formulations upon request. The Trilaciclib Dihydrochloride suppliers may include Trilaciclib Dihydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Trilaciclib Dihydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trilaciclib Dihydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Trilaciclib Dihydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Trilaciclib Dihydrochloride DMFs exist exist since differing nations have different regulations, such as Trilaciclib Dihydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trilaciclib Dihydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Trilaciclib Dihydrochloride USDMF includes data on Trilaciclib Dihydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trilaciclib Dihydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trilaciclib Dihydrochloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trilaciclib Dihydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trilaciclib Dihydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trilaciclib Dihydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trilaciclib Dihydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trilaciclib Dihydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trilaciclib Dihydrochloride suppliers with NDC on PharmaCompass.
Trilaciclib Dihydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trilaciclib Dihydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trilaciclib Dihydrochloride GMP manufacturer or Trilaciclib Dihydrochloride GMP API supplier for your needs.
A Trilaciclib Dihydrochloride CoA (Certificate of Analysis) is a formal document that attests to Trilaciclib Dihydrochloride's compliance with Trilaciclib Dihydrochloride specifications and serves as a tool for batch-level quality control.
Trilaciclib Dihydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Trilaciclib Dihydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trilaciclib Dihydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Trilaciclib Dihydrochloride EP), Trilaciclib Dihydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trilaciclib Dihydrochloride USP).
LOOKING FOR A SUPPLIER?